Right atrial myxoma originating from the tricuspid valve  by Kuroda, Hiroaki et al.
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 109, Number 6 
Brief communications 1 2 4 9 
RIGHT ATRIAL MYXOMA ORIGINATING FROM THE TRICUSPID VALVE 
Hiroaki Kuroda, MD, Kazutoyo Nitta, MD, Yasushi Ashida, MD, Yohichi Hara, MD, 
Shingo Ishiguro, MD, and Tohru Mori, MD, Yonago, Japan 
Myxoma arising from the heart valve is rare. We report 
here an unusual case of myxoma ttached to the tricuspid 
leaflet, which was successfully treated by partial excision 
of the leaflet. 
A 71-year-old man was admitted with a 1-year history of 
exertional dyspnea. The electrocardiogram showed atrial 
flutter and incomplete right bundle branch block, and the 
chest x-ray film showed mild cardiomegaly. Transthoracic 
and transesophageal chocardiograms showed a 5 by 4 cm 
mass in the right atrium originating from the lower interatrial 
septum, and prolapsing into the right ventricle through the 
tricuspid orifice during diastole (Fig. 1). A coronary anglo- 
gram showed 75% stenosis of right coronary artery (RCA) 
and the small feeding artery from the RCA. 
The patient underwent operation with the aid of cardio- 
pulmonary bypass. The right atrium contained the giant 
tumor, which was attached to the septal leaflet of the 
tricuspid valve close to the anulus. The mass was removed 
with excision of a small ellipse (about 5 mm) of valve leaflet 
at the base. The leaflet was reapproximated. Coronary artery 
bypass grafting to the RCA with a saphenous vein graft was 
added. The patient was weaned from bypass without diffi- 
culty, and an intraoperative transesophageal echocardio- 
gram showed no evidence of tricuspid regurgitation. Recov- 
ery from the operation was uneventful. A postoperative 
pulmonary perfusion scintiscan showed no defect. The tu- 
mor was rigid, 7 by 5 by 4 cm in size, and 62 gm in weight. 
The histologic diagnosis was confirmed to be myxoma, and 
there were no tumor cells in the excised leaflet. 
Primary cardiac valve tumors are uncommon, with an 
incidence of less than 10% of all cardiac tumors. In a 
recent review, ~ 56 valve tumors occurring in 53 patients 
over a 58-year period were documented. Forty-one of 
these tumors (73%) were fibroelastomas, and five of them 
(8.9%) were myxomas. Although myxoma can occur on 
the tricuspid valve, 2"3 mitral valve, 1'4 and pulmonary 
valve, 5 it appears that valvular involvement is more com- 
mon on the right side than on the left side. Cole and 
associates 2 ummarized the 11 tricuspid valve myxomas. 
Five of them had tumor attachment on the atrial side of 
the valves like our case. There seem to be no distinct 
clinical features that would lead to the diagnosis of 
involvement of the tricuspid valve. Before the advent of 
echocardiography, diagnoses of valve tumor were difficult 
and often made at autopsy. The reports of this rare 
condition will certainly increase with more cases of even 
small tumors being referred for evaluation after echocar- 
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Fig. 1. Two-dimensional echocardiogram shows right 
atrial mass prolapsing into right ventricle during diastole. 
RV, Right ventricle; TV,, tricuspid valve; AO, aorta; LA, 
left atrium; RA, right atrium. 
diographic identification. Valve tumors should be man- 
aged surgically by complete xcision to avoid recurrence 
of the tumor. In our patient, the location of the tumor on 
a septal eaflet of the tricuspid valve and its small attach- 
ment made conservation of the valve possible. 
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THE EFFECTS OF THE RATE OF REOXYGENATION ON THE RECOVERY OF 
HYPOXEMIC HEARTS 
Antonio Corno, MD, a Michele Samaja, PhD, b Stefania Casalini, PhD, b and Sonia Allibardi, PhD, c Milan, Italy 
The myocardial damage induced by the "reoxygenation 
phenomenon" of hypoxic hearts is well known from both 
14 5 experimental - and clinical reports. The surgical repair 
of cyanotic congenital heart defects in infants may be 
complicated by the problem of acute reoxygenation at the 
beginning of cardiopulmonary b pass (CPB). 5 In fact, at 
the onset of CPB the whole body and, therefore, the 
myocardium are suddenly perfused from the arterial ine 
with an oxygen saturation and an oxygen tension (Po2) 
(generally >200 mm Hg) substantially higher than the 
baseline value because of the underlying cyanotic ongen- 
ital heart defect. The main responsibility for the heart 
injury has been clinically associated with the burst of 
oxygen-derived free radicals when cyanotic hearts are 
suddenly exposed to high oxygen pressures. 5 
To test the hypothesis that the rate of reoxygenation 
may be critical in the observed pattern, we performed an 
experimental study in which isolated rat hearts were 
exposed to acute hypoxia and then underwent either 
"fast" or "slow" reoxygenation: the recovery of ventricular 
performance was then compared with the mode of the 
reoxygenation. Isolated rat hearts, perfused with Krebs- 
Henseleit buffer with a coronary flow of 15 ml/min, 3after 
a period of stabilization with 100% oxygen saturation, 
were exposed to 20 minutes of hypoxic perfusion (coro- 
nary flow of 15 ml/min, oxygen saturation 10% of base- 
line). Reoxygenation was either "fast" (Poe increase >200 
mm Hg/sec) or "slow" (Po 2 increase 2 mm Hg/sec). 
The results (Table I) indicate that both the systolic and 
diastolic ventricular functions were more depressed after 
"fast" reoxygenation than after "slow" reoxygenation. 
Although it is difficult to transfer esults gathered in an 
isolated heart preparation to an in vivo situation, from this 
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Table I 
p 
Fast Value Slow 
n 5 5 
Rate of reoxygenation (mm Hg/sec) 200 2 
Recovery (% of baseline) 
Developed pressure 46 ± 7 0.1 62 --- 5 
+dP/dt 48 + 5 0.005 70 _+ 3 
-dP/dt 48 --- 10 NS 61 ± 4 
Oxygen uptake 57 - 8 NS 68 ± 9 
Change over baseline 
End-diastolic pressure (mm Hg) 40 _ 9 0.09 22 _+ 3 
Coronary pressure (ram Hg) 37 ± 18 NS 28 ± 7 
dP/dt, Rate of pressure rise; NS, not significant. 
experimental study it appears that (1) gradual reoxygen- 
ation after hypoxia may contribute to the reduction of 
myocardial injury in infants with cyanosis who undergo 
cardiac repair with the use of CPB; (2) the persisting 
myocardial dysfunction after reoxygenation u derlines the 
presence of factors responsible for the reoxygenation 
damage other than oxygen free radicals3; (3) the bulk of 
the injury may be associated with events that occur not 
only during the reoxygenation, but most likely also during 
hypoxia, such as the high energy demand4; and (4) other 
experimental nd clinical studies are required to learn 
how to prevent or reduce the reoxygenation phenomenon. 
We are already aware of other centers of pediatric 
cardiac surgical care in which CPB in infants with cyanosis 
is routinely initiated with an arterial Po e (80 to 100 mm 
Hg) lower than that generally used and maintained at a 
relatively lower value (maximum 120 mm Hg) than that 
conventionally used (Pedro Del Nido, personal communi- 
cation, 1994). 
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